Nurix Therapeutics, Inc.
NRIX
42 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Oct 15 9:00 PM | Gwenn HansenChief Scientific Officer | Sale | 1,452 | $25.00 | $36.3K | 117,227(D) | View → |
| Oct 14, 2026 | Oct 14 8:14 PM | JULIA GREGORY | Proposed Sale | 22,583 | $23.40 | $528.5K | — | View → |
| Oct 14, 2026 | Oct 14 8:11 PM | Julia P GregoryDirector | Sale | 22,583 | $23.40 | $528.5K | 10,750(D) | View → |
| Oct 2, 2026 | Oct 2 9:21 PM | Christine RingChief Legal Officer | Sale | 5,786 | $23.19 | $134.1K | 9,110(D) | View → |
| Oct 2, 2026 | Oct 2 8:19 PM | CHRISTINE RING | Proposed Sale | 5,786 | $23.34 | $135.0K | — | View → |
| Sep 2, 2026 | Sep 2 11:42 PM | Christine RingChief Legal Officer | Sale | 5,787 | $25.76 | $149.1K | 9,110(D) | View → |
| Sep 2, 2026 | Sep 2 8:30 PM | CHRISTINE RING | Proposed Sale | 5,787 | $26.04 | $150.7K | — | View → |
| Sep 1, 2026 | Sep 1 9:19 PM | Gwenn HansenChief Scientific Officer | Sale | 1,452 | $25.47 | $37.0K | 117,227(D) | View → |
| Aug 5, 2026 | Aug 5 10:59 PM | Gwenn HansenChief Scientific Officer | Sale | 4,356 | $25.00 | $108.9K | 117,227(D) | View → |
| Aug 5, 2026 | Aug 5 8:24 PM | GWENN HANSEN | Proposed Sale | 8,712 | $24.69 | $215.1K | — | View → |
| Aug 4, 2026 | Aug 5 10:39 AM | Gwenn HansenChief Scientific Officer | Sale | 4,111 | $24.36 | $100.1K | 117,227(D) | View → |
| Aug 4, 2026 | Aug 5 1:41 AM | Houte Hans VanChief Financial Officer | Sale | 4,761 | $24.36 | $116.0K | 40,166(D) | View → |
| Aug 4, 2026 | Aug 4 8:34 PM | GWENN M HANSEN | Proposed Sale | 4,111 | $23.22 | $95.5K | — | View → |
| Aug 4, 2026 | Aug 4 8:33 PM | JOHANNES VAN HOUTE | Proposed Sale | 4,761 | $23.22 | $110.6K | — | View → |
| Aug 3, 2026 | Aug 3 9:51 PM | Christine RingChief Legal Officer | Sale | 16,589 | $23.05 | $382.4K | 9,110(D) | View → |
| Aug 3, 2026 | Aug 3 8:38 PM | CHRISTINE RING | Proposed Sale | 16,589 | $23.21 | $385.0K | — | View → |
| Jul 30, 2026 | Jul 30 9:58 PM | Houte Hans VanChief Financial Officer | Sale | 2,845 | $23.38 | $66.5K | 44,927(D) | View → |
| Jul 30, 2026 | Jul 30 9:56 PM | Christine RingChief Legal Officer | Sale | 3,847 | $23.38 | $90.0K | 19,912(D) | View → |
| Jul 30, 2026 | Jul 30 9:50 PM | Gwenn HansenChief Scientific Officer | Sale | 3,847 | $23.38 | $90.0K | 121,338(D) | View → |
| Jul 2, 2026 | Jul 2 10:02 PM | Christine RingChief Legal Officer | Sale | 11,008 | $23.56 | $259.4K | 13,579(D) | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | May 15 9:37 PM | Julia P GregoryDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| Apr 30, 2026 | Apr 30 9:38 PM | Houte Hans VanChief Financial Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Apr 30, 2026 | Apr 30 9:37 PM | Christine RingChief Legal Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Apr 30, 2026 | Apr 30 9:35 PM | Gwenn HansenChief Scientific Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Feb 10, 2026 | Feb 10 11:09 PM | Houte Hans VanChief Financial Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:55 PM | Christine RingChief Legal Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:50 PM | Gwenn HansenChief Scientific Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:43 PM | SANDS ARTHUR TDirector, President, CEO | Grant/Award | 562,500 | $16.45 | 562,500(D) | View → |
| Feb 3, 2026 | Feb 4 2:12 AM | Gwenn HansenChief Scientific Officer | Option Exercise | 31,333 | $0.84 | 0(D) | View → |
| Jan 30, 2026 | Jan 31 1:39 AM | Houte Hans VanChief Financial Officer | Option Exercise | 11,496 | — | 25,725(D) | View → |
| Jan 30, 2026 | Jan 31 1:38 AM | Christine RingChief Legal Officer | Option Exercise | 10,534 | — | 25,725(D) | View → |
| Jan 30, 2026 | Jan 31 1:36 AM | Gwenn HansenChief Scientific Officer | Option Exercise | 11,816 | — | 25,725(D) | View → |
| Jan 20, 2026 | Jan 21 12:57 AM | Christine RingChief Legal Officer | Option Exercise | 3,760 | $1.86 | 8,643(D) | View → |
← Previous
Page 2 of 2